Thiazolidinediones: antidiabetic agents with effects on bone.
Françoise
F
Debiais
D000368:Aged; D000818:Animals; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000139:chemically induced*; D001842:Bone and Bones / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D051379:Mice; D010024:Osteoporosis / Q000139:chemically induced; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077205:Pioglitazone